GEN - Genetic Engineering & Biotech NewsOriginal article
Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01
PartnershipGF-CART01Positive
AI Analysis
Summary
Cellares and GenomeFrontier Therapeutics announced a partnership to evaluate automated manufacturing of GenomeFrontier's virus-free CAR-T process for clinical manufacturing in the U.S., marking Cellares' first collaboration with an Asian cell therapy developer.
Importance:6/10
Sentiment:
0.40
Cell TherapyCAR-TAutomated ManufacturingPartnershipAsia
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on September 16, 2026 6:04 PM